| 摘要 |
<p>This invention pertains to a method of treating diseases caused by herpes viruses, including in particular Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA), achieves a selective and specific inhibition of viral function in diseases caused by HSV 1 and 2. The TEA can be provided in the form of its choloride salt, unpreserved for individual doses, or with preservatives for multiple dose vials. The mechanism of action of TEA in this treatment is disclosed as that of a ganglionic blocker, and as such, TEA has the capability of limiting the duration of HSV induced disease and its recurrences by making mammalian cells impenetrable to the HSV 1 and 2. (Patent App. Spec. - Page 1 - Joseph A. Baldone, M.D.)</p> |
